Indivior PLC $INDV Shares Newly Acquired by NINE MASTS CAPITAL Ltd

NINE MASTS CAPITAL Ltd bought a new stake in Indivior PLC (NASDAQ:INDV – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 20,000 shares of the company’s stock, valued at approximately $717,000.

A number of other large investors have also recently made changes to their positions in the company. Intech Investment Management LLC grew its stake in Indivior by 0.4% during the 3rd quarter. Intech Investment Management LLC now owns 108,262 shares of the company’s stock worth $3,881,000 after buying an additional 444 shares during the last quarter. Alberta Investment Management Corp purchased a new stake in Indivior in the third quarter valued at approximately $5,737,000. Virtus Advisers LLC lifted its stake in Indivior by 24.9% in the third quarter. Virtus Advisers LLC now owns 7,871 shares of the company’s stock valued at $282,000 after buying an additional 1,570 shares during the last quarter. Danske Bank A S lifted its stake in Indivior by 90.8% in the third quarter. Danske Bank A S now owns 1,101,966 shares of the company’s stock valued at $39,505,000 after buying an additional 524,489 shares during the last quarter. Finally, JW Asset Management LLC acquired a new stake in shares of Indivior in the third quarter valued at approximately $358,000. 60.33% of the stock is owned by institutional investors and hedge funds.

Indivior Stock Up 0.2%

INDV opened at $28.21 on Monday. The business has a 50 day moving average price of $34.24 and a two-hundred day moving average price of $35.48. The company has a market cap of $3.33 billion, a PE ratio of 7.88 and a beta of 0.84. Indivior PLC has a 52 week low of $27.68 and a 52 week high of $42.81.

Indivior (NASDAQ:INDV – Get Free Report) last posted its quarterly earnings data on Thursday, October 29th. The company reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.06 by $0.26. Indivior had a negative return on equity of 418.04% and a net margin of 32.75%. The company had revenue of $356.00 million during the quarter, compared to analysts’ expectations of $329.35 million. As a group, sell-side analysts expect that Indivior PLC will post 3.66 EPS for the current fiscal year.

Indivior Announces Dividend

The business also recently declared a special dividend, which was paid on Friday, November 6th. Stockholders of record on Friday, October 30th were paid a dividend of $8.13 per share. The ex-dividend date was Tuesday, November 3rd.

Wall Street Analysts Forecast Growth

INDV has been the topic of a number of research reports. Craig Hallum restated a “buy” rating and set a $53.00 target price on shares of Indivior in a research report on Tuesday, August 4th. Zacks Research upgraded shares of Indivior from a “hold” rating to a “strong-buy” rating in a research report on Friday, October 2nd. Barclays increased their price target on shares of Indivior from $43.00 to $45.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 28th. Weiss Ratings cut shares of Indivior from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Thursday, September 24th. Finally, Wall Street Zen lowered shares of Indivior from a “strong-buy” rating to a “buy” rating in a research note on Saturday, October 31st. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $46.40.

Read Our Latest Report on Indivior

Insider Activity at Indivior

In related news, CAO Woodrow D. Anderson purchased 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, August 27th. The stock was purchased at an average cost of $35.69 per share, with a total value of $53,535.00. Following the completion of the acquisition, the chief accounting officer directly owned 27,638 shares in the company, valued at $986,400.22. This trade represents a 5.74% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. 0.74% of the stock is owned by company insiders.

About Indivior

(Free Report)

Indivior is a specialty pharmaceutical company focused on developing and providing treatments for substance use disorders and serious mental illness. Its products include medicines for opioid use disorder, such as Sublocade, a long-acting injectable form of buprenorphine, and Suboxone, a buprenorphine-and-naloxone treatment. The company also markets Opvee, a nasal spray used to reverse opioid overdose, and Perseris, a long-acting injectable treatment for schizophrenia. Indivior develops additional therapies through its research and development programs.

Featured Stories

Want to see what other hedge funds are holding INDV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Indivior PLC (NASDAQ:INDV – Free Report).

Institutional Ownership by Quarter for Indivior (NASDAQ:INDV)

Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.